Lakefront Biotherapeutics (LKFT) Earnings Analysis
Lakefront Biotherapeutics (LKFT) next reports earnings on 2026-08-10, consensus EPS -0.82265 USD. Last quarter (2026-02-23) it beat with EPS 13.9 USD vs -0.12662 USD est (+11077.7%). It has beaten estimates in 1/2 recent quarters (50%). Trailing P/E 3.40.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does LKFT next report earnings?
| Next earnings date | 2026-08-10 |
|---|---|
| Consensus EPS estimate | -0.82265 USD |
| Revenue estimate | 0.01B |
LKFT earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-23 | 13.9 USD | -0.12662 USD | +11077.7% | Beat |
| 2025-07-23 | -1.85303 USD | -0.22826 USD | -711.8% | Miss |
Beat rate: 1/2 (50%) over reported quarters with consensus data.
LKFT valuation and analyst view
| Trailing P/E | 3.40 |
|---|---|
| Trailing EPS | 7.42 USD |
| Price / book | 0.51 |
| Dividend yield | 0.00% |
| Market cap | 1.91B |
| Analyst consensus | Hold (0 buy / 1 hold / 0 sell) |
| Avg price target | 30 USD |
Related research pages
Frequently asked questions
When is Lakefront Biotherapeutics (LKFT)'s next earnings date?
Lakefront Biotherapeutics is next scheduled to report on 2026-08-10, with a consensus EPS estimate of -0.82265 USD and revenue estimate of 0.01B.
Did LKFT beat earnings last quarter?
In its 2026-02-23 report, LKFT posted EPS of 13.9 USD versus a -0.12662 USD estimate — a beat of 11077.7%.
What is LKFT's earnings track record?
Over the last 2 reported quarters with consensus data, LKFT beat estimates 1 times (50%).
What is LKFT's current P/E ratio and EPS?
LKFT trades at a trailing P/E of 3.40 on trailing EPS of 7.420051093375867 USD.
What do analysts rate LKFT?
Analyst consensus is "Hold" across 1 ratings (0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell). Average 12-month price target: 30 USD.